Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: High risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene

Haematologica

Volumn 86, Issue 9, 2001, Pages 965-971

  Santamaria A ^a   Mateo, J ^a   Oliver, A ^a   Menendez B ^a   Souto, J C ^a   Borrell, M ^a   Soria, J M ^a   Tirado, I ^a   Fontcuberta, J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Inherited thrombophilia; Oral contraceptives; Venous thromboembolism

Indexed keywords

ALANINE; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; GLYCINE; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPAIN; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTIVES, ORAL; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SPAIN; THROMBOPHILIA; THROMBOSIS;

EID: 0034786549     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pulmonary embolism
2. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism: Results of the Spanish Multicentric Study on Thrombophilia (EMET-Study)
3. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism
4. Thrombosis in the young: Epidemiology and risk factors. A focus on venous thrombosis
5. Oral contraceptives and thrombotic disease: Risk of venous thromboembolism
6. Women with thrombophilia: Assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy
7. Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception
8. A positive family history of venous thromboembolism requires an extended screening for hereditary risk factors prior to prescription of oral contraceptives
9. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study
10. The prothrombin 20210A allele is the most prevalent genetic risk factor of venous thromboembolism in the Spanish population
11. Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study)
12. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
13. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
14. The prothrombin gene variant 20210A in venous and arterial thromboembolism
15. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis
16. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication
17. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects
18. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
19. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families
20. Incidence of venous thromboembolism in families with inherited thrombophilia
21. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis
22. Venous thrombotic risk in family members of unselected individuals with factor V Leiden
23. A single salting out procedure for extracting DNA from human nucleated cells
24. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene
25. Patients with venous thrombosis have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?
26. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives